"Cell Proliferation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
| Descriptor ID |
D049109
|
| MeSH Number(s) |
G04.161.750 G07.345.249.410.750
|
| Concept/Terms |
Cell Proliferation- Cell Proliferation
- Proliferation, Cell
- Cellular Proliferation
- Proliferation, Cellular
- Cell Multiplication
- Multiplication, Cell
- Cell Growth in Number
- Cell Number Growth
- Growth, Cell Number
- Number Growth, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Proliferation".
Below are MeSH descriptors whose meaning is more specific than "Cell Proliferation".
This graph shows the total number of publications written about "Cell Proliferation" by people in this website by year, and whether "Cell Proliferation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2004 | 2 | 18 | 20 |
| 2005 | 7 | 38 | 45 |
| 2006 | 7 | 52 | 59 |
| 2007 | 5 | 47 | 52 |
| 2008 | 12 | 62 | 74 |
| 2009 | 11 | 58 | 69 |
| 2010 | 12 | 58 | 70 |
| 2011 | 8 | 79 | 87 |
| 2012 | 8 | 64 | 72 |
| 2013 | 15 | 88 | 103 |
| 2014 | 13 | 85 | 98 |
| 2015 | 13 | 89 | 102 |
| 2016 | 16 | 94 | 110 |
| 2017 | 11 | 98 | 109 |
| 2018 | 15 | 86 | 101 |
| 2019 | 14 | 63 | 77 |
| 2020 | 10 | 76 | 86 |
| 2021 | 7 | 56 | 63 |
| 2022 | 0 | 23 | 23 |
| 2023 | 0 | 23 | 23 |
| 2024 | 5 | 34 | 39 |
| 2025 | 2 | 40 | 42 |
| 2026 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Proliferation" by people in Profiles.
-
MiR-200c restoration inhibits FOXP3 and metastatic spread in breast cancer: evidence from in vitro and in vivo models. BMC Cancer. 2026 Feb 14; 26(1).
-
Myosin 5b deficiency alters liver proliferation, zonation, and bile acid composition. Hepatol Commun. 2026 Mar 01; 10(3).
-
Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth. Mol Cancer Ther. 2026 Feb 04; 25(2):257-271.
-
Evaluating the Antiproliferative Effects of Tri(2-Furyl)- and Triphenylphosphine-Gold(I) Pyridyl- and Pyrimidine-Thiolate Complexes. Biomolecules. 2026 01 15; 16(1).
-
miR-302 regulates pancreatic progenitor pool and pancreatic size. Biol Open. 2026 Jan 01; 15(1).
-
Dinaciclib improves treatment response in chemoresistant hepatoblastoma. Sci Rep. 2025 Dec 05; 16(1):1410.
-
Unconventional binding of calmodulin to CHK2 kinase inhibits catalytic activity. Biochem J. 2025 Dec 03; 482(23).
-
Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer. Cell Rep Med. 2025 Dec 16; 6(12):102474.
-
Transcriptional coregulator ZMIZ1 modulates estrogen responses that are essential for healthy endometrial function. J Clin Invest. 2025 Dec 01; 135(23).
-
Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer. Oncogene. 2025 Dec; 44(50):4868-4877.